Figure 19From: Human physiologically based pharmacokinetic model for ACE inhibitors: ramipril and ramiprilatTop: model plasma ramiprilat for entire experimental period (left) and at long times (right) following 2.5 mg (red), 5 mg(black), 10 mg (green) or 20 mg (blue) oral ramiprilat in "average" subject. Bottom: Fraction of C site (left) or N site (right) inhibited in same subject for same set of oral ramipril doses.Back to article page